National Perox.

Why is National Peroxide Ltd falling/rising?

As of 01-Sep, National Peroxide Ltd's stock price is falling, currently at 625.00, reflecting a decrease of 10.3 or 1.62%. The stock has declined for three consecutive days, underperformed its sector, and experienced reduced investor interest, despite positive financial results in recent quarters.

As of 01-Sep, National Peroxide Ltd's stock price is falling, currently at 625.00, reflecting a decrease of 10.3 or 1.62%. This decline is part of a broader trend, as the stock has been losing value for the last three days, with a total drop of 3.69% during this period. Additionally, the stock underperformed its sector by 1.2% today, indicating weaker performance compared to its peers.<BR><BR>Investor participation has also decreased, with delivery volume falling by 45.58% against the five-day average, suggesting reduced interest from investors. The stock touched an intraday low of Rs 610, which is a significant drop of 3.98%. Although the stock is trading above its longer-term moving averages (20-day, 50-day, 100-day, and 200-day), it is below the 5-day moving average, which may indicate short-term weakness.<BR><BR>Despite these negative indicators, the company has shown positive financial results in recent quarters, including a 12.13% growth in net sales and substantial increases in profit before tax and profit after tax. However, these positive results have not been enough to counteract the current downward pressure on the stock price. Overall, the combination of recent price declines, reduced investor participation, and underperformance relative to the sector contributes to the current falling trend of National Peroxide Ltd's stock.

What does National Perox. do?

National Peroxide Ltd is a micro-cap company in the commodity chemicals industry, reporting net sales of 96 Cr and a net profit of 7 Cr for June 2026. It has a market cap of INR 372 Cr, a P/E ratio of 20.00, and a return on equity of 5.15%.

Overview: <BR>National Peroxide Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History: <BR>The company was incorporated in 2020 as NPL Chemicals Limited and underwent a name change to National Peroxide Limited following a Composite Scheme of Arrangement. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 96 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 7 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 372 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 20.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.16 <BR>Return on Equity: 5.15% <BR>Price to Book: 1.04 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the National Perox.?

National Perox.'s peers include Chemfab Alka., Primo Chemicals, POCL Enterprises, Mangalam Organic, Lords Chloro, Alufluoride, Andhra Petrochem, Genus Prime, and Hind.Organ.Chem. In terms of management risk, National Perox. and Genus Prime are rated Below Average, while Alufluoride is rated Excellent; National Perox. has a 1-year return of 3.93%, higher than Chemfab Alka.'s -44.94% but lower than Genus Prime's 72.28%.

Peers: The peers of National Perox. are Chemfab Alka., Primo Chemicals, POCL Enterprises, Mangalam Organic, Lords Chloro, Alufluoride, Andhra Petrochem, Genus Prime, and Hind.Organ.Chem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride, while Average management risk is found at Chemfab Alka., Primo Chemicals, POCL Enterprises, Mangalam Organic, Lords Chloro, and Andhra Petrochem, and the rest. Below Average management risk is noted for National Perox., Genus Prime, and Hind.Organ.Chem. Growth is Excellent at POCL Enterprises, Good at Lords Chloro and Alufluoride, Below Average at Chemfab Alka., Primo Chemicals, Mangalam Organic, and Andhra Petrochem, and the rest. National Perox. and Hind.Organ.Chem. have Below Average growth, while Genus Prime shows Good growth. Capital Structure is Excellent at National Perox., Good at Alufluoride and Andhra Petrochem, Average at Primo Chemicals, and Below Average at Chemfab Alka., POCL Enterprises, Mangalam Organic, Genus Prime, and Hind.Organ.Chem.<BR><BR>Return Snapshot: Genus Prime has the highest 1-year return at 72.28%, while Chemfab Alka. has the lowest at -44.94%. National Perox.'s 1-year return of 3.93% is higher than Chemfab Alka. but lower than Genus Prime. Additionally, the peers with negative six-month returns include Chemfab Alka., POCL Enterprises, and Mangalam Organic.

How big is National Perox.?

As of 31st August, National Peroxide Ltd has a market capitalization of 372.00 Cr, with recent net sales of 319.13 Cr and a net profit of 18.06 Cr. Shareholder's funds are 349.26 Cr and total assets amount to 441.72 Cr as of March 2025.

As of 31st August, National Peroxide Ltd has a market capitalization of 372.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, National Peroxide reported Net Sales of 319.13 Cr and a Net Profit of 18.06 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 349.26 Cr and Total Assets of 441.72 Cr.

Which are the latest news on National Perox.?

Should I buy, sell or hold National Peroxide Ltd?

When is the next results date for National Peroxide Ltd?

The next results date for National Peroxide Ltd is August 3, 2026.

The next results date for National Peroxide Ltd is scheduled for August 3, 2026.

Are National Peroxide Ltd latest results good or bad?

National Peroxide Ltd's latest Q3 FY26 results show a significant net profit increase of 369.23% quarter-on-quarter and improved revenue, but concerns remain due to a history of losses, low return on equity, and a 40.21% decline in stock value over the past year, indicating mixed overall performance. Caution is advised regarding the company's future prospects.

National Peroxide Ltd's latest results for Q3 FY26 present a mixed picture. On one hand, the company reported a net profit of ₹1.83 crore, which is a significant improvement of 369.23% quarter-on-quarter. Additionally, revenue increased by 1.17% from the previous quarter, reaching ₹69.09 crore, and this marks an 11.15% increase year-on-year.<BR><BR>The operating margin also improved to 10.12%, the highest in seven quarters, suggesting some operational stability. However, this recovery comes after a challenging FY25, where the company faced a net loss of ₹2 crore on revenues of ₹286 crore, indicating a significant decline from a profit of ₹16 crore in FY24.<BR><BR>Despite these positive indicators, the overall financial health of National Peroxide remains concerning. The company has struggled with volatile margins, and its return on equity (ROE) is alarmingly low at 1.90%, with the latest quarterly ROE even dipping to -1.92%. The stock has underperformed significantly, with a one-year decline of 40.21%, contrasting sharply with the broader market's performance.<BR><BR>In summary, while there are some signs of recovery in the most recent quarter, the underlying issues, including poor historical performance and low investor confidence, suggest that the results are not entirely positive. Caution is warranted when assessing the company's future prospects.

How has been the historical performance of National Perox.?

National Perox has experienced a significant decline in financial performance over the past three years, with net sales dropping from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, resulting in a loss of -2.25 Cr in profit after tax. Key metrics such as operating profit and earnings per share also fell sharply, indicating reduced profitability and cash generation capabilities.

Answer:<BR>The historical performance of National Perox shows a decline in key financial metrics over the past three years, culminating in a loss for the year ending March 2025.<BR><BR>Breakdown:<BR>National Perox's net sales decreased from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, reflecting a downward trend in total operating income, which also fell from 375.87 Cr to 286.87 Cr during the same period. The company's total expenditure, excluding depreciation, decreased from 317.36 Cr in March 2023 to 271.66 Cr in March 2025, primarily due to a reduction in raw material costs from 191.26 Cr to 145.46 Cr. However, operating profit (PBDIT) declined significantly from 67.36 Cr in March 2023 to 19.70 Cr in March 2025, leading to a profit before tax of -2.08 Cr in March 2025, down from 53.50 Cr in March 2023. Consequently, profit after tax also turned negative, reaching -2.25 Cr in March 2025 compared to 39.50 Cr in March 2023. The company's earnings per share (EPS) reflected this downturn, dropping from 68.7 in March 2023 to -3.91 in March 2025. On the balance sheet, total liabilities decreased from 453.55 Cr in March 2023 to 441.72 Cr in March 2025, while total assets also fell from 453.55 Cr to 441.72 Cr. Cash flow from operating activities showed a decline from 67.00 Cr in March 2023 to 18.00 Cr in March 2025, indicating a significant reduction in cash generation capabilities. Overall, National Perox's financial performance has deteriorated over the past three years, resulting in losses and reduced profitability.

Who are the top shareholders of the National Perox.?

The top shareholders of National Perox include Nowrosjee Wadia And Sons Limited with 30.78% and individual investors with 24.82%. There are no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of National Perox include the promoters, with Nowrosjee Wadia And Sons Limited holding the largest stake at 30.78%. Additionally, individual investors collectively hold 24.82% of the shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

Is National Perox. overvalued or undervalued?

As of May 7, 2025, National Perox. is considered overvalued and risky, with a PE ratio of -157.63 and negative EV ratios, indicating poor financial performance compared to peers like Solar Industries and Godrej Industries, despite a recent stock return of 8.61%.

As of 7 May 2025, the valuation grade for National Perox. has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently considered overvalued. Key ratios highlight this concern: the PE ratio stands at an alarming -157.63, while the EV to EBIT ratio is also negative at -64.72, and the EV to EBITDA ratio is at 20.91. These figures suggest that the company is struggling to generate profits relative to its valuation.<BR><BR>In comparison to its peers, National Perox. shows stark contrasts. For instance, Solar Industries India Ltd. has a PE ratio of 123.77, while Godrej Industries Ltd. boasts a PE ratio of 46.63, both indicating much stronger valuations. Additionally, National Perox.'s ROE is at -0.63%, further emphasizing its underperformance relative to the industry. Despite a recent stock return of 8.61% over the past week, which outperformed the Sensex's 1.35%, the overall financial metrics suggest that investors should approach National Perox. with caution.

What is the technical trend for National Perox.?

As of June 6, 2025, National Perox's technical trend has shifted to a moderate bearish stance, indicated by daily moving averages and weekly KST readings, despite some mixed signals from the Dow Theory and weekly MACD.

As of 6 June 2025, the technical trend for National Perox has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators include the daily moving averages showing a mildly bearish trend, while the weekly KST is bearish. The Dow Theory indicates a mildly bullish stance on the weekly but remains bearish on the monthly, suggesting mixed signals. The MACD on the weekly is mildly bullish, but the overall sentiment leans bearish due to the prevailing moving averages and KST readings.

Has National Perox. declared dividend?

Yes, National Peroxide Ltd has declared a 125% dividend, amounting to ₹12.5 per share, with an ex-date of August 20, 2024. However, the company's total returns have been negative in the last 6 months and stagnant over the past several years.

National Peroxide Ltd has declared a 125% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 125%<BR>- Amount per share: 12.5<BR>- Ex-date: 20 Aug 24<BR><BR>Dividend Yield: 2.05%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.82%, the dividend return was 0%, resulting in a total return of -30.82%.<BR><BR>Over the past year, there was no price return, no dividend return, leading to a total return of 0.0%.<BR><BR>In the 2-year period, the price return remained at 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>For the 3-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>In the 4-year period, there was a price return of 0%, no dividend return, leading to a total return of 0.0%.<BR><BR>Finally, in the 5-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, while National Peroxide Ltd has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the short term with a notable decline in price return.